Sylvain Lanthier

1. de Boysson H et al. Data-Driven Clustering Approach to Identify Different Phenotypes of Primary Central Nervous System Vasculitis. Eur J Neurol 2025;32:e70174. doi: 10.1111/ene.70174.
2. Farjat-Pasos JI et al. Determinants of adverse outcomes following patent foramen ovale closure in elderly patients. EuroIntervention. 2024;20:1029-1038. doi: 10.4244/EIJ-D-24-00156.
3. Grangeon L et al. Cerebral Amyloid Angiopathy-Related Inflammation and Biopsy-Positive Primary Angiitis of the CNS: A Comparative Study. Neurology 2024;103:e209548. doi: 10.1212/WNL.0000000000209548.
4. Farjat-Pasos JI et al. Cerebrovascular Events in Older Patients With Patent Foramen Ovale: Current Status and Future Perspectives. J Stroke 2023;25:338-349. doi: 10.5853/jos.2023.01599.
5. Nehme A et al. Comparison of patients with biopsy positive and negative primary angiitis of the central nervous system. Rheumatology 2024;63:1973-1979. doi: 10.1093/rheumatology/kead542.
6. Blais J et al. Ischemic stroke is a potential complication of uncontrolled inflammation in mevalonate kinase deficiency - A case report. J Stroke Cerebrovasc Dis 2022;106780. doi: 10.1016/j.jstrokecerebrovasdis.2022.106780.
7. Ladhani NNN et al. Canadian Stroke Best Practice Consensus Statement: Acute Stroke Management during pregnancy. Int J Stroke. 2018;13:743-758. doi: 10.1177/1747493018786617.
8. Swartz RH et al. Canadian stroke best practice consensus statement: Secondary stroke prevention during pregnancy. Int J Stroke 2018;13:406-419. doi: 10.1177/1747493017743801.
9. Lanthier S et al. Prevalence of Fabry Disease and Outcomes in Young Canadian Patients With Cryptogenic Ischemic Cerebrovascular Events. Stroke 2017;48:1766-1772. doi: 10.1161/STROKEAHA.116.016083.
10. Moussaddy A et al. Inflammatory Cerebral Amyloid Angiopathy, Amyloid-β-Related Angiitis, and Primary Angiitis of the Central Nervous System: Similarities and Differences. Stroke 2015;46:e210-213. doi: 10.1161/STROKEAHA.115.010024.
11. Boudjani H et al. Striatum inhibition: clues for cocaine addiction therapy. Can J Neurol Sci 2014;41:664-665. doi: 10.1017/cjn.2014.13.
12. Bérubé MD et al. Neurologic manifestations of Henoch-Schönlein purpura. Handb Clin Neurol. 2014;120:1101-1111. doi: 10.1016/B978-0-7020-4087-0.00074-7.
13. Shi Q et al. Prevalence of Fabry disease in stroke patients--a systematic review and meta-analysis. J Stroke Cerebrovasc Dis 2014;23:985-992. doi: 10.1016/j.jstrokecerebrovasdis.2013.08.010.
14. Gioia LC et al. Silent ischemic lesions in young adults with first stroke are associated with recurrent stroke. Neurology 2012;79:1208-1214. doi: 10.1212/WNL.0b013e31826aacac.
15. Darsaut T et al. In TIA or stroke patients with intracranial arterial stenosis, aggressive medical therapy was superior to percutaneous transluminal angioplasty and stenting for 30-day risk of further stroke or death. Evid Based Med. 2012;17:115-116. doi: 10.1136/ebmed-2011-100451.
16. De Tiege X et al. Primary angiitis of the central nervous system: neurologic deterioration despite treatment Pediatrics 2011;127:e1086-1090. doi: 10.1542/peds.2009-2729.
17. Lanthier S et al. Post-varicella arteriopathy of childhood: natural history of vascular stenosis. Neurology 2005;64:660-663. doi: 10.1212/01.WNL.0000151851.66154.27.
18. Lanthier S et al. Increased anticardiolipin antibody IgG titers do not predict recurrent stroke or TIA in children. Neurology 2004;62:194-200. doi: 10.1212/wnl.62.2.194.
19. Lanthier S. Primary angiitis of the central nervous system in children: 10 cases proven by biopsy. J Rheumatol 2002;29:1575-1576.
20. Lanthier S et al. Isolated angiitis of the CNS in children. Neurology 2001;56:837-842. doi: 10.1212/wnl.56.7.837.
21. Lanthier S et al. Stroke in children: the coexistence of multiple risk factors predicts poor outcome. Neurology 2000;54:371-378. doi: 10.1212/wnl.54.2.371.